Ayijiang Taledaohan Selected Research

Neoplasms (Cancer)

2/2024	Structure-Activity Relationship of PAD4 Inhibitors and Their Role in Tumor Immunotherapy.
12/2023	The Promoting Role of HK II in Tumor Development and the Research Progress of Its Inhibitors.
12/2023	Chitosan nanomedicine containing RGD peptide and PAD4 inhibitor based on phenyl boronate coupling inhibition of primary tumor growth and lung metastasis.
1/2021	RGD Peptide and PAD4 Inhibitor-Loaded Gold Nanorods for Chemo-Photothermal Combined Therapy to Inhibit Tumor Growth, Prevent Lung Metastasis and Improve Biosafety.
1/2020	TAT-Modified Gold Nanoparticles Enhance the Antitumor Activity of PAD4 Inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ayijiang Taledaohan Research Topics

Disease

5	Neoplasms (Cancer) 02/2024 - 01/2020
2	Neoplasm Metastasis (Metastasis) 12/2023 - 01/2021
1	Ischemic Stroke 01/2023

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 02/2024 - 12/2023
2	arginyl-glycyl-aspartic acidIBA 12/2023 - 01/2021
2	Peptides (Polypeptides)IBA 12/2023 - 01/2020
2	YW3-56IBA 12/2023 - 01/2020
2	GoldIBA 01/2021 - 01/2020
1	Protein-Arginine Deiminase Type 4IBA 02/2024
1	HexokinaseIBA 12/2023
1	Biological FactorsIBA 12/2023
1	EnzymesIBA 12/2023
1	ChitosanIBA 12/2023
1	EdaravoneIBA 01/2023
1	Human immunodeficiency virus 1 tat peptide (49-57)IBA 01/2020
1	Histones (Histone)IBA 01/2020
1	Protein-Arginine DeiminasesIBA 01/2020

Therapy/Procedure

3	Therapeutics 12/2023 - 01/2020
1	Immunotherapy 02/2024
1	Lasers (Laser) 01/2021
1	Nanospheres 01/2021